This past November, CMS announced that starting January 1, 2023, Medicare will pay physicians in all states and other practitioners with prescription authority, such as nurse practitioners (NPs) and physician assistants (PAs) in some states, to perform comprehensive pain management for their patients living with chronic pain. Medicare health insurance covers individuals over the age of 65 and disabled Americans.
CMS has created 2 specialized billing codes just for chronic pain management (Healthcare Common Procedure Coding System codes G3002 and G3003) that these health care practitioners can use to get paid for their time spent caring for patients and coordinating patient care with other health care practitioners, like physical therapists, psychologists, and even complementary practitioners, such as massage therapists and acupuncturists.
Did CMS include patient input in the ruling?
Yes! CMS released a draft version of this idea in July 2022 and posed many questions asking for patient and other stakeholder input. The U.S. Pain Foundation sent an alert this summer explaining the kinds of input they were seeking. Thank you to those who took action! U.S. Pain Foundation submitted a lengthy comment to the docket answering CMS’s questions from the patient perspective. You can read our comment here. We are pleased that CMS really did incorporate our recommendations into the final rule. In fact, they quoted the organization’s comment 12 times in the final rule.
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen
What We’re Reading: New HPV Screenings; Lung Cancer Pills; Migraine Relief Device
November 9th 2023A study suggests that human papillomavirus (HPV) screenings should be updated due to effective HPV vaccines; a new study shows that osimertinib (Tagrisso, AstraZeneca) reduced both the 5-year risk of recurrent cancer and the risk of death in patients with stage 1B to 3A lung cancer; a new smartphone-controlled technology could help those who suffer from migraines.
Read More